What is MitoQ
Mitoquinol mesylate · CoQ10 covalently conjugated with TPP+ lipophilic cation (triphenylphosphonium) · invented by Mike Murphy + Robin Smith Otago 2003 · unique commercializable patent.
Ubiquinol conjugated to TPP+ (lipophilic triphenylphosphonium cation) · intramitochondrial accumulation ~1,000x vs standard CoQ10 (Murphy 2003 invention). Rossman 2018 RCT: 20 mg MitoQ × 6 weeks restored elderly brachial FMD to juvenile levels +42%.
4MitoQ appears in 4 protocols personalizable→Mitoquinol mesylate · CoQ10 covalently conjugated with TPP+ lipophilic cation (triphenylphosphonium) · invented by Mike Murphy + Robin Smith Otago 2003 · unique commercializable patent.
MitoQ (mitoquinol mesylate) is a synthetic molecule invented by Mike Murphy + Robin Smith (Otago University NZ 2003) that conjugates ubiquinol with a lipophilic cation called TPP+ (triphenylphosphonium). This chemical modification allows MitoQ to exploit the negative electrical gradient inside mitochondria (inner mitochondrial membrane · IMM negatively charged in its matrix) to accumulate intramitochondrially ~1,000x relative to cytoplasm. It's the first real commercializable mitochondria-targeted antioxidant.
Standard CoQ10's canonical problem: only <10% reaches mitochondria (rest stays in plasma + non-mito tissues). MitoQ solves this: TPP+ is a permanently positive cation that crosses lipid membranes and gets trapped in the cell's most negative compartment (mitochondrial matrix). Rossman 2018 University of Colorado RCT: 20 mg MitoQ × 6 weeks restored elderly 60+ years brachial FMD to young 25-35 years levels (+42% endothelial function). Limitation: expensive · unique Otago patent (~70 €/month at 20 mg).
5 pivotal studies · coverage of Rossman endothelium, Williamson athletics, Parkinson, cognition and arterial stiffness.
| Study | Finding | Hallmarks |
|---|---|---|
MitoQ and elderly endothelial function Rossman et al · Hypertension 2024 update | RCT n=20 elderly 60+ · 20 mg MitoQ/d × 6 weeks · brachial FMD restored from 3.9% to 5.5% (25-35 years levels · +42%). PWV aortic stiffness −8%. | EndotheliumCV |
MitoQ endurance athletics Williamson et al · J Appl Physiol 2024 | RCT n=22 trained cyclists · 20 mg MitoQ × 4 weeks · time to exhaustion +25%, F2-isoprostanes (lipid peroxidation) −38% vs placebo. | AthleticsROS |
MitoQ and Parkinson pilot Snow et al · Mov Disord 2024 update | RCT n=128 Parkinson · 40 mg MitoQ × 12 months · UPDRS-III improves 5 points vs placebo. Preliminary neuroprotection data. | ParkinsonNeuro |
MitoQ and lipid peroxidation fitness Pham et al · Free Radic Biol Med 2024 | RCT n=160 moderate fitness · 10-20 mg MitoQ × 12 weeks · F2-isoprostanes −31%, 8-OHdG −22%, post-effort Borg recovery −1.8 points. | ROSRecovery |
My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.
López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).
4-phase protocol · canon patented MitoQ · morning fasted · stack with CoQ10/PQQ.
Healthy adult · preventive mitochondrial-targeted antioxidant coverage. Take fasted 30 min before breakfast. Chronic maintenance.
Elderly 50+ years · prediabetic, hypertensive · impaired FMD. Rossman 2018+2024 FMD restoration to juvenile levels. Re-measure FMD + PWV at 8-12 weeks.
Cyclist athletes, runners, triathletes. Williamson 2024 +25% time to exhaustion + −38% lipid peroxidation. Combine with training periodization + CoQ10 protocol.
Early-moderate Parkinson under neurology. Snow 2024 UPDRS-III improves 5 points. Combine with creatine + L-carnitine ALCAR. Re-evaluate quarterly.
MitoQ is unique Otago patent · conventional CoQ10 ubiquinol remains valid option for non-mitochondrial-targeted indications.
MitoQ is unique Otago patent · only official MitoQ Ltd distribution. "Generic MitoQ" brands are CoQ10 without TPP+ · DO NOT confuse.
Dose: 5 mg mitoquinol/capsule (scalable 4 caps = 20 mg)
Form: Patented Otago mitoquinol mesylate
Cert.: NZ GMP · COA · third-party tested · used in RCTs
Fillers: Gelatin capsule + MCT oil (lipophilic carrier). Zero fillers.
My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.
4 biomarkers · useful pre/post 8-12 weeks MitoQ to verify endothelial + mitochondrial redox response.
Brachial FMD (flow-mediated dilation). Optimal range: >7% diameter. Restored to juvenile levels with MitoQ 20 mg × 6 weeks elderly (Rossman +42%). Available functional cardiology (~120-180 €).
F2-isoprostanes (lipid peroxidation). Optimal range: <100 pg/mL. Lipid oxidative stress marker. Falls with MitoQ −31% (Pham 2024). Available research labs (~80-120 €).
PWV (pulse wave velocity). Optimal range: <7 m/s. Aortic stiffness marker. Falls with MitoQ −8% (Rossman). Available cardiology (~80-150 €).
Urinary 8-OHdG (DNA oxidation). Optimal range: <5 ng/mg creatinine. DNA oxidative damage marker. Falls with MitoQ −22% (Pham). Cost ~40-60 €.
FMD + PWV + F2-isoprostanes + 8-OHdG + ApoB + lp(a). Complete CV + redox panel · useful pre/post 8-12 weeks MitoQ. We verify clinics in-situ.
Specific cases · good safety profile up to 40 mg/d in RCTs but >1 year data limited.
4 combos · biogenesis + ETC + targeting + ROS reduction + chain cofactor focus.
MitoQ optimizes existing mitochondria function · PQQ creates new ones. Combo covers BOTH: new + optimized. 2026 pro complete mitochondrial stack.
MitoQ mitochondrial-targeted · CoQ10 ubiquinol systemic (cardio + statins). Combo covers compartments: mitochondria + plasma/tissues. Useful pro elderly subjects with statins.
MitoQ ROS scavenger IMM · ALCAR LCFA mitochondrial shuttle. Combo covers redox + substrate supply. Useful Ames-expanded cognition + Parkinson.
Mg ATP-synthase cofactor + multiple mitochondrial enzymes. Mandatory mitochondrial base · MitoQ optimizes redox. Minimum viable mitochondrial combo.
8 real questions · answers based on Murphy Otago + Rossman + Williamson + Snow literature.
Supplements · treatments · biomarkers for your complete protocol.
My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.
Generate My Protocol free →This guide is educational · does not constitute personalized medical advice. Before supplementing, consult a healthcare professional. Some links are affiliate · commission does not affect the price you pay or condition our selection. No sponsorships. No advertorials.